Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability

9Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: The authors tested the hypothesis that p42/44- (ERK-1/2) and/ or p38-mitogen-activated protein kinases (MAPK) are in vivo regulatory elements in the platelet-activating factor (PAF) activated signaling cascade that stimulates microvascular hyperpermeability. Methods: FITC-dextran 70 was used as the macromolecular tracer for microvascular permeability in the mouse mesenteric fat tissue. Interstitial integrated optical intensity (IOI) was used as an index of permeability. Results: An application of 10-7M PAF increased IOI from 23.1 ± 3.6 to 70.8 ± 7.4 (mean ± SEM). Inhibition of ERK-1/2 with 3 μM and 30 μM AG126 reduced IOI to 32.3 ± 2.5. Similarly, inhibition of p38-MAPK with 6 nM, 60 nM and 600 nM SB203580 lowered IOI to 29.1 ± 2.4. Conclusions: The results demonstrate that ERK-1/2 and p38MAPK participate in the signaling cascade that regulates PAF-induced microvascular hyperpermeability in vivo. Copyright © 2005 Taylor & Francis Inc.

Cite

CITATION STYLE

APA

Yu, P., Hatakeyama, T., Aramoto, H., Miyata, T., Shigematsu, H., Nagawa, H., … Durán, W. N. (2005). Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability. Microcirculation, 12(8), 637–643. https://doi.org/10.1080/10739680500301706

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free